HLS in the World: New Technologies, New Dilemmas: Part of the HLS200 Bicentennial Celebration
This event was part of the HLS in the World sessions of HLS │200, a bicentennial summit of academic sessions and programs devoted to legal issues of pressing importance.
New technologies with implications for human health and enhancement are developing at breakneck speed, with fundamental changes in genomic medicine, reproductive technology, neuroscience, and even how we die. Each of these technologies raises important questions at the intersection of ethics, law, and politics. What role should the government have in regulating scientific innovation? How should we weigh potential risks and benefits, to individuals, vulnerable populations, and even the environment? Can these technologies be used to promote justice, or do they risk entrenching existing disparities? This group of speakers discussed these pressing questions, and more, from their perspectives as lawyers, scientists, and clinicians.
I. Glenn Cohen '03, Professor of Law, Harvard Law School, and Faculty Director, The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School
Judith Edersheim '85, Co-Founder and Co-Director of the Center for Law, Brain and Behavior, Massachusetts General Hospital; Assistant Clinical Professor of Psychiatry, Harvard Medical School; and attending Psychiatrist in the Department of Psychiatry, Massachusetts General Hospital
Atul Gawande, Executive Director, Ariadne Labs
Eric Lander, President and Founding Director, The Broad Institute of MIT and Harvard
Moderator: Carmel Shachar '10, Executive Director, The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School
This event was sponsored by Harvard Law School as part of the HLS │200 bicentennial celebrations.
bioethics biotechnology carmel shachar end-of-life enhancement environment genetics health law policy human rights i. glenn cohen innovation medicine neuroscience public health regulation reproductive technologies research